Peer-reviewed research and clinical trials supporting Arthrosamid® polyacrylamide hydrogel injection for sustained knee osteoarthritis pain relief lasting up to 5 years.
Explore the peer-reviewed studies supporting Arthrosamid® hydrogel injection for knee osteoarthritis.
Multicentre randomised controlled trial evaluating the safety and performance of Arthrosamid® (iPAAG) in patients with knee osteoarthritis, demonstrating significant pain reduction at 52 weeks.
Long-term follow-up study demonstrating sustained pain relief and functional improvement up to 156 weeks (3 years) following a single Arthrosamid® injection.
Prospective cohort study evaluating the effectiveness of intra-articular polyacrylamide hydrogel injection in patients with symptomatic knee osteoarthritis in clinical practice.
Study examining the mechanism of action through which Arthrosamid® integrates with the synovial membrane and reduces inflammatory cytokine activity in osteoarthritic joints.
Retrospective analysis of over 6,000 patients treated with polyacrylamide hydrogel injection for knee osteoarthritis, confirming a favourable long-term safety profile.
Comparative study evaluating polyacrylamide hydrogel versus hyaluronic acid injections for knee osteoarthritis, demonstrating superior long-term outcomes with iPAAG.
Five-year follow-up data from clinical studies showing sustained WOMAC pain score improvements and maintained functional outcomes from a single Arthrosamid® injection.
Evaluation of patient-reported outcomes and quality of life improvements following Arthrosamid® treatment for moderate knee osteoarthritis across multiple European centres.
Book a consultation to discuss whether Arthrosamid® injection is right for your knee osteoarthritis.
Trusted by patients across the UK